Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis
- PMID: 12953099
- DOI: 10.1200/JCO.2003.11.069
Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis
Abstract
Purpose: The epidermal growth factor receptor (EGFR) is frequently overexpressed in non-small-cell lung carcinoma (NSCLC), and EGFR inhibitors are promising new therapeutic agents. The molecular mechanisms responsible for EGFR overexpression are poorly understood.
Materials and methods: Gene copy number and protein status of EGFR were investigated in microarrayed tumors from 183 NSCLC patients, including squamous cell carcinoma (SCC; 89 patients) and non-SCC (94 patients) histologies. Protein expression was assessed by immunohistochemistry on a scale from 0 to 400 (percentage of positive cells x staining intensity). Gene and chromosome 7 copy numbers were identified by fluorescent in situ hybridization (FISH).
Results: EGFR protein overexpression was observed in 62% of the NSCLC (25% scored 201 to 300; 37% scored 301 to 400), more frequently in SCC than non-SCC (82% v 44%; P <.001), and in 80% of the bronchioloalveolar carcinomas. The prevalent FISH patterns were balanced disomy (40%) and trisomy (38%) for EGFR gene and chromosome 7 (40%), whereas balanced polysomy was seen in 13% and gene amplification was seen in 9% of the patients. Gene copy number correlated with protein expression (r = 0.4; P <.001). EGFR overexpression or high gene copy numbers had no significant influence on prognosis.
Conclusion: EGFR overexpression is frequent in NSCLC, is most prominent in SCC, and correlates with increased gene copy number per cell. High gene copy numbers per cell showed a trend toward poor prognosis. It will be important to evaluate EGFR gene and EGFR protein status and signal protein expression to properly interpret future clinical trials using EGFR inhibitors.
Comment in
-
Epidermal growth factor receptor overexpression: the importance of context.J Clin Oncol. 2003 Dec 1;21(23):4268-9. doi: 10.1200/JCO.2003.05.988. Epub 2003 Oct 27. J Clin Oncol. 2003. PMID: 14581439 No abstract available.
-
Testing for epidermal growth factor receptor in lung cancer: have we learned anything from HER-2 testing?J Clin Oncol. 2004 Sep 1;22(17):3646; author reply 3646-8. doi: 10.1200/JCO.2004.99.015. J Clin Oncol. 2004. PMID: 15337816 No abstract available.
Similar articles
-
Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.J Clin Oncol. 2005 Oct 1;23(28):6838-45. doi: 10.1200/JCO.2005.01.2823. Epub 2005 Jul 5. J Clin Oncol. 2005. PMID: 15998906 Clinical Trial.
-
Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study.Lung Cancer. 2010 Jun;68(3):375-82. doi: 10.1016/j.lungcan.2009.07.014. Epub 2009 Aug 26. Lung Cancer. 2010. PMID: 19712993
-
Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.Lung Cancer. 2009 Jun;64(3):295-300. doi: 10.1016/j.lungcan.2008.10.005. Epub 2008 Dec 5. Lung Cancer. 2009. PMID: 19058870
-
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.Lung Cancer. 2003 Aug;41 Suppl 1:S29-42. doi: 10.1016/s0169-5002(03)00137-5. Lung Cancer. 2003. PMID: 12867060 Review.
-
Molecular biology, genomics, and proteomics in bronchioloalveolar carcinoma.J Thorac Oncol. 2006 Nov;1(9 Suppl):S8-12. J Thorac Oncol. 2006. PMID: 17410000
Cited by
-
VASH2 enhances KIF3C-mediated EGFR-endosomal recycling to promote aggression and chemoresistance of lung squamous cell carcinoma by increasing tubulin detyrosination.Cell Death Dis. 2024 Oct 23;15(10):772. doi: 10.1038/s41419-024-07155-x. Cell Death Dis. 2024. PMID: 39443476 Free PMC article.
-
Human Uterine Rudiments: Histological and Immunohistochemical Study.Bull Exp Biol Med. 2021 May;171(1):87-93. doi: 10.1007/s10517-021-05178-4. Epub 2021 May 31. Bull Exp Biol Med. 2021. PMID: 34057616
-
In vivo photoacoustic tomography of EGFR overexpressed in hepatocellular carcinoma mouse xenograft.Photoacoustics. 2016 Apr 22;4(2):43-54. doi: 10.1016/j.pacs.2016.04.001. eCollection 2016 Jun. Photoacoustics. 2016. PMID: 27766208 Free PMC article.
-
Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer.Oncotarget. 2015 Sep 15;6(27):23582-93. doi: 10.18632/oncotarget.4361. Oncotarget. 2015. PMID: 26160838 Free PMC article.
-
Upregulation of epidermal growth factor receptor 4 in oral leukoplakia.Int J Oral Sci. 2013 Mar;5(1):14-20. doi: 10.1038/ijos.2013.10. Epub 2013 Mar 15. Int J Oral Sci. 2013. PMID: 23492901 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous